Rosiglitazone dampens pulmonary inflammation in a porcine model of acute lung injury

Inflammation

Volumn 37, Issue 4, 2014, Pages 1102-1110

  Mirakaj, Valbona ^a   Mutz, Christian ^b   Vagts, Dierk ^b   Henes, Janek ^a   Haeberle, Helene A ^a   Husung, Susanne ^b   König, Tony ^b   Nöldge Schomburg, Gabriele ^b   Rosenberger, Peter ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

acute lung injury; cytokine; inflammation; rosiglitazone

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; ENDOTOXIN; PEROXIDASE;

ACUTE LUNG INJURY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL PIG; LUNG HEMODYNAMICS; NONHUMAN; OXYGENATION; PNEUMONIA; PROTEIN EXPRESSION; ANIMAL; BRONCHOSCOPY; CATHETERIZATION; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; HEMODYNAMICS; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG; LUNG ALVEOLUS; LUNG LAVAGE; METABOLISM; SWINE;

SUS;

ACUTE LUNG INJURY; ADMINISTRATION, INHALATION; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CATHETERIZATION; DISEASE MODELS, ANIMAL; ENDOTOXINS; HEMODYNAMICS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INFUSIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; LUNG; PEROXIDASE; PULMONARY ALVEOLI; SWINE; THIAZOLIDINEDIONES;

EID: 84904748815     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9834-0     Document Type: Article

References (29)

1. Ware, L.B., and M.A. Matthay. 2000. The acute respiratory distress syndrome. The New England Journal of Medicine 342: 1334-1349. (Pubitemid 30408719)
2. Reutershan, J., and K. Ley. 2004. Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Critical Care 8: 453-461. (Pubitemid 40073680)
3. Reutershan, J., M.A. Morris, T.L. Burcin, D.F. Smith, D. Chang, M.S. Saprito, et al. 2006. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. The Journal of Clinical Investigation 116: 695-702. (Pubitemid 43326878)
4. Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli. 2000. Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. American Journal of Physiology - Lung Cellular and Molecular Physiology 279: L1137-L1145. (Pubitemid 32009500)
5. Azoulay, E., M. Darmon, C. Delclaux, F. Fieux, C. Bornstain, D. Moreau, et al. 2002. Deterioration of previous acute lung injury during neutropenia recovery. Critical Care Medicine 30: 781-786. (Pubitemid 34297794)
6. Ranieri, V.M., F. Giunta, P.M. Suter, and A.S. Slutsky. 2000. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA: The Journal of the American Medical Association 284: 43-44. (Pubitemid 30445657)
7. Parsons, P.E., M.D. Eisner, B.T. Thompson, M.A. Matthay, M. Ancukiewicz, G.R. Bernard, et al. 2005. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Critical Care Medicine 33: 1-6. discussion 230-2.
8. Brower, R.G., P.N. Lanken, N. MacIntyre, M.A. Matthay, A. Morris, M. Ancukiewicz, et al. 2004. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. The New England Journal of Medicine 351: 327-336.
9. Meduri, G.U., S. Headley, G. Kohler, F. Stentz, E. Tolley, R. Umberger, et al. 1995. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest 107: 1062-1073.
10. Meduri, G.U., G. Kohler, S. Headley, E. Tolley, F. Stentz, and A. Postlethwaite. 1995. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 108: 1303-1314.
11. Blanquart, C., O. Barbier, J.C. Fruchart, B. Staels, and C. Glineur. 2003. Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. The Journal of Steroid Biochemistry and Molecular Biology 85: 267-273. (Pubitemid 37011102)
12. Ricote, M., A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass. 1998. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391: 79-82. (Pubitemid 28079218)
13. Jiang, C., A.T. Ting, and B. Seed. 1998. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86. (Pubitemid 28079219)
14. Liu, D., B.X. Zeng, S.H. Zhang, Y.L. Wang, L. Zeng, Z.L. Geng, et al. 2005. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats. Critical Care Medicine 33: 2309-2316. (Pubitemid 41437486)
15. Liu, D., B.X. Zeng, S.H. Zhang, and S.L. Yao. 2005. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflammation Research 54: 464-470. (Pubitemid 41690375)
16. Chen, C., S. Xu, W.X. Wang, Y.M. Ding, K.H. Yu, B. Wang, et al. 2009. Rosiglitazone attenuates the severity of sodium taurocholate-induced acute pancreatitis and pancreatitis-associated lung injury. Archives of Medical Research 40: 79-88.
17. Mutz, C., V. Mirakaj, D.A. Vagts, P. Westermann, K. Waibler, K. Konig, et al. 2010. The neuronal guidance protein netrin-1 reduces alveolar inflammation in a porcine model of acute lung injury. Critical Care 14: R189.
18. Rosenthal, C., C. Caronia, C. Quinn, N. Lugo, and M. Sagy. 1998. A comparison among animal models of acute lung injury. Critical Care Medicine 26: 912-916. (Pubitemid 28211403)
19. Anderson, W.R., and K. Thielen. 1992. Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastructural Pathology 16: 615-628.
20. Weiland, J.E., W.B. Davis, J.F. Holter, J.R. Mohammed, P.M. Dorinsky, and J.E. Gadek. 1986. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. The American Review of Respiratory Disease 133: 218-225. (Pubitemid 16123913)
21. Amato, M.B., C.R. Carvalho, A. Isola, S. Vieira, V. Rotman, M. Moock, et al. 2007. Mechanical ventilation in acute lung injury (ALI)/acute respiratory discomfort syndrome (ARDS). Jornal Brasileiro de Pneumologia 33(Suppl 2S): S119-S127.
22. Amato, M.B., C.S. Barbas, D.M. Medeiros, R.B. Magaldi, G.P. Schettino, G. Lorenzi-Filho, et al. 1998. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. The New England Journal of Medicine 338: 347-354. (Pubitemid 28083906)
23. Harmon, G.S., D.S. Dumlao, D.T. Ng, K.E. Barrett, E.A. Dennis, H. Dong, et al. 2010. Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice. Nature Medicine 16: 313-318.
24. Cuzzocrea, S., B. Pisano, L. Dugo, A. Ianaro, N.S. Patel, R. Di Paola, et al. 2004. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice. Critical Care Medicine 32: 457-466. (Pubitemid 38234126)
25. Zingarelli, B., M. Sheehan, P.W. Hake, M. O'Connor, A. Denenberg, and J.A. Cook. 2003. Peroxisome proliferator activator receptor-gamma ligands, 15-deoxy-Delta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. Journal of Immunology 171: 6827-6837. (Pubitemid 37532118)
26. Khandoudi, N., P. Delerive, I. Berrebi-Bertrand, R.E. Buckingham, B. Staels, and A. Bril. 2002. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury. Diabetes 51: 1507-1514. (Pubitemid 34826618)
27. Eckle, T., K. Hartmann, S. Bonney, S. Reithel, M. Mittelbronn, L.A. Walker, et al. 2012. Adora2b-elicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nature Medicine 18: 774-782.
28. Bonney, S., D. Kominsky, K. Brodsky, H. Eltzschig, L. Walker, and T. Eckle. 2013. Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart. PLoS One 8: e71493.
29. Genovese, T., E. Mazzon, R. Di Paola, C. Muia, M.D. Threadgill, A.P. Caputi, et al. 2005. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. Journal of Pharmacology and Experimental Therapeutics 313: 529-538. (Pubitemid 40604151)